The Relevance of Implementing the Systematic Screening of Perioperative Myocardial Injury in Noncardiac Surgery Patients

Otros/as autores/as

Institut Català de la Salut

[Popova E] Institut d’Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain. Centro Cochrane Iberoamericano, Barcelona, Spain. [Paniagua-Iglesias P] Department of Anesthesia and Pain Management, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [Álvarez-García J] Department of Cardiology, Hospital Universitario Ramon y Cajal, Madrid, Spain. Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. [Vives-Borrás M] Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Department of Cardiology, Fundació Institut d’Investigació Sanitària Illes Balears (IdISBa), Palma, Spain. [González-Osuna A] Department of Orthopedic Surgery and Traumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [García-Osuna Á] Department of Biochemistry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [Aguilar-Lopez R] Institut d’Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain. Unitat d’Epidemiologia Clínica, Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Fecha de publicación

2023-09-20T08:37:50Z

2023-09-20T08:37:50Z

2023-08-18



Resumen

Noncardiac surgery; Perioperative myocardial injury; Screening


Cirugía no cardíaca; Lesión miocárdica perioperatoria; Cribado


Cirurgia no cardíaca; Lesió miocàrdica perioperatòria; Cribratge


Perioperative myocardial injury (PMI) is a common cardiac complication. Recent guidelines recommend its systematic screening using high-sensitivity cardiac troponin (hs-cTn). However, there is limited evidence of local screening programs. We conducted a prospective, single-center study aimed at assessing the feasibility and outcomes of implementing systematic PMI screening. Hs-cTn concentrations were measured before and after surgery. PMI was defined as a postoperative hs-cTnT of ≥14 ng/L, exceeding the preoperative value by 50%. All patients were followed-up during the hospitalization, at one month and one year after surgery. The primary outcome was the incidence of death and major cardiovascular and cerebrovascular events (MACCE). The secondary outcomes focused on the individual components of MACCE. We included two-thirds of all eligible high-risk patients and achieved almost complete compliance with follow-ups. The prevalence of PMI was 15.7%, suggesting a higher presence of cardiovascular (CV) antecedents, increased perioperative CV complications, and higher preoperative hs-cTnT values. The all-cause death rate was 1.7% in the first month, increasing up to 11.2% at one year. The incidence of MACCE was 9.5% and 8.6% at the same time points. Given the observed elevated frequencies of PMI and MACCE, implementing systematic PMI screening is recommendable, particularly in patients with increased cardiovascular risk. However, it is important to acknowledge that achieving optimal screening implementation comes with various challenges and complexities.


This study was supported by a research grant from Fundació La Marató de TV3 (20150110).

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Publicado por

MDPI

Documentos relacionados

Journal of Clinical Medicine;12(16)

https://doi.org/10.3390/jcm12165371

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

Este ítem aparece en la(s) siguiente(s) colección(ones)